{
    "2018-05-07": [
        [
            {
                "time": "",
                "original_text": "推荐评级医药行业周报：基本面和政策面驱动医药板块持续向好",
                "features": {
                    "keywords": [
                        "医药",
                        "基本面",
                        "政策面",
                        "板块",
                        "向好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股正式“入摩”近在咫尺，外资机构重点布局股曝光",
                "features": {
                    "keywords": [
                        "A股",
                        "入摩",
                        "外资",
                        "布局"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[路演]泰格医药：订单签署呈现良好态势",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "订单",
                        "良好态势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]泰格医药(300347)：归母净利润增长61% CRO龙头持续受益于创新药产业链服务价值提升",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利润增长",
                        "CRO",
                        "龙头",
                        "创新药",
                        "产业链",
                        "服务价值提升"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：医药浪潮有望填平低估洼地 消费升级盛夏高潮迭起",
                "features": {
                    "keywords": [
                        "医药生物",
                        "浪潮",
                        "低估值",
                        "消费升级",
                        "高潮迭起"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}